Gilead wins European approval for HIV prevention injection
Go back to Gilead wins European approval for HIV prevention injection| Gilead Sciences (NASDAQ: GILD) | Delayed: 143.44 -4.16 (2.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.60 | 52 Week High | $108.63 | |||
| Open | $146.69 | 52 Week Low | $71.39 | |||
| Day High | $146.82 | P/E | 79.25 | |||
| Day Low | $143.19 | EPS | $1.81 | |||
| Volume | 7,160,206 | |||||

